ABcann Appoints New Chief Marketing Officer
January 05 2018 - 7:00AM
ABCANN GLOBAL CORPORATION (TSX-V:ABCN)
(“
ABcann” or the “
Company”) is
pleased to announce the appointment of Sung Kang as the Company's
Chief Marketing Officer (CMO). Mr. Kang, who will assume the
position effective January 8, 2018, was formerly the Head of
Marketing for the Mike’s Beverage Company, Canada’s leading
ready-to-drink and cider business, owned by Labatt Breweries of
Canada.
With more than 17 years of marketing experience,
Mr. Kang has also held senior marketing leadership roles at
companies including General Mills, Novartis Consumer Health, and
Mark Anthony Group. His diverse background in consumer packaged
goods (CPG)/food, pharma and alcohol has given him extensive
experience managing large brand portfolios as well as uncovering
powerful consumer insights that lead to category expanding new
product innovations within regulated industries.
“Sung is a great addition to the leadership
team. We believe his marketing expertise combined with his
experience in the alcohol and consumer health industries will prove
invaluable to ABcann’s future growth,” says Barry Fishman, Chief
Executive Officer of ABcann. “He knows how to leverage marketing
analytics to create unique brands and effective promotions, and has
a proven record of pushing the boundaries of consumer brands using
disruptive innovation.”
As ABcann’s CMO, Mr. Kang will lead the
Company’s branding, product innovation, customer marketing,
consumer insights and advertising, as well as market access, key
account management and digital initiatives. He will be responsible
for developing and executing strategies aimed at positioning ABcann
as a leading medical and adult-use cannabis company and driving
profitable revenue.
In connection with Mr. Kang’s appointment, the
Company has agreed to grant Mr. Kang 300,000 stock options, each of
which will be exercisable into one common share in the capital of
the Company until January 5, 2023 at a price of $1.77 per share,
being the closing price per share on the TSX Venture Exchange on
January 4, 2018. The options will vest quarterly over 36
months.
About ABcann:
ABcann holds production and sales licenses from
Health Canada. Its flagship facility in Napanee, Ontario contains
proprietary plant-growing technology, centred on its specially
designed, environmentally-controlled growing chambers. This
approach results in the production of pharmaceutical-grade cannabis
products.
The Company is expanding its cultivation
capacity and pursuing partnership and product development
opportunities domestically, as well as in select international
markets, such as Germany, Australia and Israel.
ON BEHALF OF THE BOARD OF DIRECTORS
"Barry Fishman"
Barry Fishman CEO and Director
Neither TSX Venture Exchange nor its Regulation
Services Provider (as that term is defined in the policies of the
TSX Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
Disclaimer for Forward-Looking Information
Certain statements in this news release are
forward-looking statements, which are statements that are not
purely historical, regarding the beliefs, plans, expectations or
intentions of ABcann and its management regarding the future.
Forward looking statements in this news release include statements
relating to the expected impact of Mr. Kang’s appointment on
ABcann’s operation, his ability to develop and execute strategies
to position ABcann as a leader in the cannabis sector and to drive
profitable revenue, and ABcann’s future plans with respect to
cultivation, distribution and imports into Germany, Australia and
other international jurisdictions. Such statements are subject to
risks and uncertainties that may cause actual results, performance
or developments to differ materially from those contained in the
forward-looking statements, including that Mr. Kang will not have
the expected impact on ABcann’s operations, the strategies to be
developed will not grow ABcann’s business as expected, and other
factors beyond the Company’s control. No assurance can be given
that any of the events anticipated by the forward-looking
statements will occur or, if they do occur, what benefits the
Company will obtain from them. Readers are urged to consider these
factors, and the more extensive risk factors included in the
Company’s filing statement dated March 31, 2017, which is available
on SEDAR, carefully in evaluating the forward-looking statements,
and are cautioned not to place undue reliance on such
forward-looking statements, which are qualified in their entirety
by these cautionary statements. The forward-looking statements in
this news release are made as of the date hereof and the Company
disclaims any intent or obligation to update publicly any such
forward-looking statements, whether as a result of new information,
future events or results or otherwise, except as required by
applicable securities laws.
For further information, please contact:
• Barry Fishman (CEO and Director) at barry.fishman@abcannglobal.com
• Michael Bumby (CFO) at michael.bumby@abcannglobal.com
Abcann Global Corporation (TSXV:ABCN)
Historical Stock Chart
From Jun 2024 to Jul 2024
Abcann Global Corporation (TSXV:ABCN)
Historical Stock Chart
From Jul 2023 to Jul 2024